Nasopharyngeal Carcinoma in Childhood and Adolescence: A Single Institution'S Experience of 158 Patients
W. Liu,J. Yi,L. Gao,X. Huang,J. Luo,S. Li,S. Zhang,Y. Qu,K. Wang,G. Xu
DOI: https://doi.org/10.1016/j.ijrobp.2014.05.1604
2014-01-01
Abstract:Purpose/Objective(s)Nasopharyngeal carcinoma (NPC) is rare in children, no consensus on the treatment strategy for children with NPC was established. The aim of this study is to evaluate the clinical features, treatment results, prognostic factors and treatment related late toxicities of NPC in childhood and adolescence less than 20 years of age.Materials/MethodsBetween January 1990 and January 2011, 158 pathologically confirmed NPC patients with age <20 years old were treated in our institution. There were 9 (5.7%) in stage II, 60 (38.0%) in stage III and 89 (56.3%) in stage IV when evaluated by UICC2002 staging system. The median radiation dose to primary tumor was 74 Gy (range, 49-91Gy). The median dose to metastatic cervical lymph nodes was 68 Gy (48-82 Gy). 85 (53.8%) patients received radiation therapy alone, while 73 (46.2%) patients were treated with combined modality therapy.Results128 patients were still alive with a median follow-up of 62.5 months (range, 2.0-225.0 months). Neck mass (32.3%), headache (21.5%) and nasal obstruction (15.2%) were the most common chief complaints. The 5-year overall survival (OS), local-regional control (LRC) and distant metastasis-free survival (DMFS) were 82.6%, 94.9% and 76.4%, respectively. There were 43 (27.2%) patients relapsed during the follow up, with 7 local-regional recurrence and 38 distant metastasis. In univariate analysis, T4, stage IV, radiation dose <70 Gy were statistically significant factors for worse OS. In multivariate analysis, the only adverse prognostic factor for OS was radiation dose <70 Gy. The late toxicities were evaluated in 41 patients. The most common late toxicities were neck fibrosis (97.6%), xerostomia (87.8%), hearing loss (39.0%), endocrine dysfunctions (31.7%) and trismus (19.5%), while hypothyroidism (92.3%) was the most common endocrine defect. A significant reduction in late toxicities of hearing loss and trismus was noted with the use of IMRT.ConclusionsThe results of treating NPC in childhood and adolescence with radiation therapy alone or chemoradiation therapy were excellent in our institution. Reducing distant metastasis with new strategy and late toxicities with intensity modulated radiation therapy are the future directions for the treatment of children and adolescent nasopharyngeal carcinoma. Purpose/Objective(s)Nasopharyngeal carcinoma (NPC) is rare in children, no consensus on the treatment strategy for children with NPC was established. The aim of this study is to evaluate the clinical features, treatment results, prognostic factors and treatment related late toxicities of NPC in childhood and adolescence less than 20 years of age. Nasopharyngeal carcinoma (NPC) is rare in children, no consensus on the treatment strategy for children with NPC was established. The aim of this study is to evaluate the clinical features, treatment results, prognostic factors and treatment related late toxicities of NPC in childhood and adolescence less than 20 years of age. Materials/MethodsBetween January 1990 and January 2011, 158 pathologically confirmed NPC patients with age <20 years old were treated in our institution. There were 9 (5.7%) in stage II, 60 (38.0%) in stage III and 89 (56.3%) in stage IV when evaluated by UICC2002 staging system. The median radiation dose to primary tumor was 74 Gy (range, 49-91Gy). The median dose to metastatic cervical lymph nodes was 68 Gy (48-82 Gy). 85 (53.8%) patients received radiation therapy alone, while 73 (46.2%) patients were treated with combined modality therapy. Between January 1990 and January 2011, 158 pathologically confirmed NPC patients with age <20 years old were treated in our institution. There were 9 (5.7%) in stage II, 60 (38.0%) in stage III and 89 (56.3%) in stage IV when evaluated by UICC2002 staging system. The median radiation dose to primary tumor was 74 Gy (range, 49-91Gy). The median dose to metastatic cervical lymph nodes was 68 Gy (48-82 Gy). 85 (53.8%) patients received radiation therapy alone, while 73 (46.2%) patients were treated with combined modality therapy. Results128 patients were still alive with a median follow-up of 62.5 months (range, 2.0-225.0 months). Neck mass (32.3%), headache (21.5%) and nasal obstruction (15.2%) were the most common chief complaints. The 5-year overall survival (OS), local-regional control (LRC) and distant metastasis-free survival (DMFS) were 82.6%, 94.9% and 76.4%, respectively. There were 43 (27.2%) patients relapsed during the follow up, with 7 local-regional recurrence and 38 distant metastasis. In univariate analysis, T4, stage IV, radiation dose <70 Gy were statistically significant factors for worse OS. In multivariate analysis, the only adverse prognostic factor for OS was radiation dose <70 Gy. The late toxicities were evaluated in 41 patients. The most common late toxicities were neck fibrosis (97.6%), xerostomia (87.8%), hearing loss (39.0%), endocrine dysfunctions (31.7%) and trismus (19.5%), while hypothyroidism (92.3%) was the most common endocrine defect. A significant reduction in late toxicities of hearing loss and trismus was noted with the use of IMRT. 128 patients were still alive with a median follow-up of 62.5 months (range, 2.0-225.0 months). Neck mass (32.3%), headache (21.5%) and nasal obstruction (15.2%) were the most common chief complaints. The 5-year overall survival (OS), local-regional control (LRC) and distant metastasis-free survival (DMFS) were 82.6%, 94.9% and 76.4%, respectively. There were 43 (27.2%) patients relapsed during the follow up, with 7 local-regional recurrence and 38 distant metastasis. In univariate analysis, T4, stage IV, radiation dose <70 Gy were statistically significant factors for worse OS. In multivariate analysis, the only adverse prognostic factor for OS was radiation dose <70 Gy. The late toxicities were evaluated in 41 patients. The most common late toxicities were neck fibrosis (97.6%), xerostomia (87.8%), hearing loss (39.0%), endocrine dysfunctions (31.7%) and trismus (19.5%), while hypothyroidism (92.3%) was the most common endocrine defect. A significant reduction in late toxicities of hearing loss and trismus was noted with the use of IMRT. ConclusionsThe results of treating NPC in childhood and adolescence with radiation therapy alone or chemoradiation therapy were excellent in our institution. Reducing distant metastasis with new strategy and late toxicities with intensity modulated radiation therapy are the future directions for the treatment of children and adolescent nasopharyngeal carcinoma. The results of treating NPC in childhood and adolescence with radiation therapy alone or chemoradiation therapy were excellent in our institution. Reducing distant metastasis with new strategy and late toxicities with intensity modulated radiation therapy are the future directions for the treatment of children and adolescent nasopharyngeal carcinoma.